C.V. Damaraju

426 total citations
11 papers, 354 citations indexed

About

C.V. Damaraju is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, C.V. Damaraju has authored 11 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 4 papers in Internal Medicine and 4 papers in Economics and Econometrics. Recurrent topics in C.V. Damaraju's work include Atrial Fibrillation Management and Outcomes (9 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). C.V. Damaraju is often cited by papers focused on Atrial Fibrillation Management and Outcomes (9 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). C.V. Damaraju collaborates with scholars based in United States, Canada and Belgium. C.V. Damaraju's co-authors include Craig I Coleman, Winnie W. Nelson, Jeffrey Schein, François Laliberté, Patrick Lefèbvre, William H. Olson, Michel Cloutier, Dominic Pilon, Xue Song and David M. Smith and has published in prestigious journals such as Journal of the American College of Cardiology, Thrombosis Research and Journal of Occupational and Environmental Medicine.

In The Last Decade

C.V. Damaraju

10 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.V. Damaraju United States 8 335 197 39 32 19 11 354
Steve Deitelzweig United States 10 456 1.4× 250 1.3× 70 1.8× 77 2.4× 5 0.3× 22 494
Anja Katholing Australia 4 277 0.8× 83 0.4× 49 1.3× 30 0.9× 10 0.5× 7 295
Franziska Ebertz Germany 4 469 1.4× 343 1.7× 31 0.8× 15 0.5× 8 0.4× 8 496
Bettina Ammentorp Germany 5 433 1.3× 145 0.7× 46 1.2× 48 1.5× 8 0.4× 11 448
Alan John Camm United Kingdom 10 629 1.9× 155 0.8× 73 1.9× 60 1.9× 6 0.3× 15 670
Peter J Svensson Sweden 13 480 1.4× 207 1.1× 70 1.8× 26 0.8× 3 0.2× 19 521
Lauren Uyeda United States 5 205 0.6× 83 0.4× 24 0.6× 26 0.8× 9 0.5× 6 230
Shihai Lu Netherlands 12 339 1.0× 106 0.5× 54 1.4× 39 1.2× 14 0.7× 24 353
Gloria Kayani United Kingdom 8 461 1.4× 168 0.9× 106 2.7× 46 1.4× 5 0.3× 15 503
Philomeen Kuijer Netherlands 3 282 0.8× 256 1.3× 41 1.1× 15 0.5× 2 0.1× 4 330

Countries citing papers authored by C.V. Damaraju

Since Specialization
Citations

This map shows the geographic impact of C.V. Damaraju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.V. Damaraju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.V. Damaraju more than expected).

Fields of papers citing papers by C.V. Damaraju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.V. Damaraju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.V. Damaraju. The network helps show where C.V. Damaraju may publish in the future.

Co-authorship network of co-authors of C.V. Damaraju

This figure shows the co-authorship network connecting the top 25 collaborators of C.V. Damaraju. A scholar is included among the top collaborators of C.V. Damaraju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.V. Damaraju. C.V. Damaraju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Nelson, Winnie W., Xue Song, David M. Smith, et al.. (2015). Medication persistence and discontinuation of rivaroxaban and dabigatran etexilate among patients with non-valvular atrial fibrillation. Current Medical Research and Opinion. 31(10). 1831–1840. 27 indexed citations
3.
Page, Robert L., Vahram Ghushchyan, Brian Gifford, et al.. (2014). Hidden Costs Associated With Venous Thromboembolism. Journal of Occupational and Environmental Medicine. 56(9). 979–985. 13 indexed citations
4.
Nelson, Winnie W., Li Wang, Onur Başer, C.V. Damaraju, & Jeffrey Schein. (2014). Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation. Journal of Medical Economics. 18(5). 333–340. 6 indexed citations
5.
Laliberté, François, M. Cloutier, Craig I Coleman, et al.. (2014). Real-World Comparative Effectiveness And Safety Of Rivaroxaban And Warfarin In Nonvalvular Atrial Fibrillation Patients. Value in Health. 17(3). A102–A103. 47 indexed citations
6.
Laliberté, François, Craig I Coleman, Brahim Bookhart, et al.. (2014). Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagulants. Current Medical Research and Opinion. 30(8). 1513–1520. 16 indexed citations
7.
Nelson, Winnie W., Xue Song, Craig I Coleman, et al.. (2014). Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation. Current Medical Research and Opinion. 30(12). 2461–2469. 67 indexed citations
8.
Nelson, Winnie W., et al.. (2014). International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation. Current Medical Research and Opinion. 30(12). 2437–2442. 12 indexed citations
9.
Laliberté, François, Michel Cloutier, Winnie W. Nelson, et al.. (2014). Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients. Current Medical Research and Opinion. 30(7). 1317–1325. 155 indexed citations
10.
Choi, Jiyoon, C.V. Damaraju, Roger M. Mills, et al.. (2012). IMPACT OF COMORBIDITIES ON TIME IN THERAPEUTIC RANGE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 59(13). E1855–E1855. 3 indexed citations
11.
Mills, Roger M., Richard Berkowitz, C.V. Damaraju, Lisa K. Jennings, & Peter Wildgoose. (2012). Initiation of rivaroxaban following low molecular weight heparin for thromboprophylaxis after total joint replacement: The Safe, Simple Transitions (SST) study. Thrombosis Research. 130(5). 709–715. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steve Deitelzweig Breakdown of academic impact, for papers by Anja Katholing Breakdown of academic impact, for papers by Franziska Ebertz Breakdown of academic impact, for papers by Bettina Ammentorp Breakdown of academic impact, for papers by Alan John Camm Breakdown of academic impact, for papers by Peter J Svensson Breakdown of academic impact, for papers by Lauren Uyeda Breakdown of academic impact, for papers by Shihai Lu Breakdown of academic impact, for papers by Gloria Kayani Breakdown of academic impact, for papers by Philomeen Kuijer
Rankless by CCL
2026